Relay Therapeutics, Inc. (RLAY) Operating income 2019–2025
Relay Therapeutics, Inc. (RLAY) annual operating income history from SEC filings — each fiscal year as reported.
-$302.7MFY2025 · since FY2019: -$84.0M → -$302.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$302.7M | +18.7% |
| FY2024 | -$372.5M | +0.1% |
| FY2023 | -$373.0M | -24.6% |
| FY2022 | -$299.3M | +17.9% |
| FY2021 | -$364.7M | -553.6% |
| FY2020 | -$55.8M | +33.6% |
| FY2019 | -$84.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice